4-(2,4-Dichlorophenyl)-N-propyl-1,3-thiazol-2-amine

Catalog No. :
ACUCXK017
CAS No. :
556009-97-3
Molecular Formula :
C12H12Cl2N2S
Molecular Weight :
287.21

IUPAC Name:4-(2,4-dichlorophenyl)-N-propylthiazol-2-amine

4-(2,4-Dichlorophenyl)-N-propyl-1,3-thiazol-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$70.00Login to see priceInquiryInquiry
100mg95%$100.00Login to see priceInquiryInquiry
250mg95%$132.00Login to see priceInquiryInquiry
1g95%$337.00Login to see priceInquiryInquiry
5g95%$946.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(2,4-Dichlorophenyl)-N-propyl-1,3-thiazol-2-amine
IUPAC Name4-(2,4-dichlorophenyl)-N-propylthiazol-2-amine
MDL No.MFCD04608665
Molecular FormulaC12H12Cl2N2S
Molecular Weight287.21
SMILESCCCNC1=NC(C2=CC=C(Cl)C=C2Cl)=CS1
InChI KeyIFWTVDLKDVFWIG-UHFFFAOYSA-N
Synonym4-(2,4-dichlorophenyl)-N-propyl-1,3-thiazol-2-amine;2-Thiazolamine, 4-(2,4-dichlorophenyl)-N-propyl-
CAS No.556009-97-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACUCXK017 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXRMT175 route compound structure diagram
    ACXRMT175927-67-3 In Stock
  2. Plus
  3. ACPYCD326 route compound structure diagram
    ACPYCD3262631-72-3 In Stock
  4. Then
  5. ACUCXK017 route product structure diagram
    ACUCXK017556009-97-3
Inquiry

2. ACUCXK017 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFMGD954 route compound structure diagram
    ACFMGD95493209-97-3 In Stock
  4. Then
  5. ACUCXK017 route product structure diagram
    ACUCXK017556009-97-3
Inquiry

Comments (0)